VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

8301	Companies
115073	Keywords
55420	Articles
62512	Press releases

Home
Companies
VALBIOTIS

BRIEF

published on 07/05/2024 at 08:35, 4 months 16 days ago

Valbiotis: Number of shares and voting rights as of June 30, 2024

Share Capital Voting Rights AMF Valbiotis Threshold Crossings
BRIEF

published on 07/05/2024 at 08:35, 4 months 16 days ago

Valbiotis: Monthly information on voting rights and shares - June 2024

Share Capital Voting Rights Valbiotis Regulatory Information
BRIEF

published on 06/26/2024 at 08:35, 4 months 25 days ago

Valbiotis - Combined Annual General Meeting of June 25, 2024: Voting results

Shareholders Valbiotis Resolutions General Assembly Food Supplements
BRIEF

published on 06/20/2024 at 08:55, 5 months 1 day ago

Valbiotis: Monthly information relating to the total number of voting rights and shares - May 2024

Voting Rights Actions Euronext Growth Valbiotis Statuses
BRIEF

published on 06/20/2024 at 08:55, 5 months 1 day ago

Valbiotis: Monthly information relating to the total number of voting rights and shares - May 2024

Voting Rights Actions Euronext Growth Valbiotis Threshold Crossing
BRIEF

published on 06/17/2024 at 17:45, 5 months 4 days ago

Valbiotis to present at American Diabetes Association sessions

Diabetes Valbiotis American Diabetes Association TOTUM•63 Food Supplements
PRESS RELEASE

published on 06/17/2024 at 17:40, 5 months 4 days ago

Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results from TOTUM•63 Phase II/III REVERSE-IT study in prediabetes and type 2 diabetes at the American Diabetes Association’s 84th Scientific Sessions

Valbiotis American Diabetes Association TOTUM•63 Clinical Results Scientific Sessions
BRIEF

published on 06/06/2024 at 10:58, 5 months 15 days ago

Valbiotis Terminate Licensing Agreement with Nestlé Health Science

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
PRESS RELEASE

published on 06/06/2024 at 10:53, 5 months 15 days ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis regains full ownership of TOTUM•63, a plant-based dietary supplement for prediabetes and early type 2 diabetes, after terminating agreement with Nestlé Health Science

Valbiotis Dietary Supplement TOTUM•63 Nestlé Health Science Prediabetes
BRIEF

published on 06/06/2024 at 10:49, 5 months 15 days ago

Valbiotis and Nestlé Health Science terminate their licensing and supply agreement

Valbiotis Intellectual Property TOTUM•63 Food Supplements Nestlé

Accesswire

Published on 11/21/2024 at 17:35, 42 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 47 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 47 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 16 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 17 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 17:58, 18 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 25 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 26 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 16:00, 2 hours 17 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 2 hours 35 minutes ago

Edison issues report on Murray Income Trust (MUT)

Les Echos

Published on 11/21/2024 at 06:58, 11 hours 19 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 57 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE